FIM
RVMD icon

Fernwood Investment Management’s Revolution Medicines RVMD Stock Holding History

Fernwood Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$809K Hold
18,505
– – 0.28% 74
2024
Q3 		$839K Hold
18,505
– – 0.27% 86
2024
Q2 		$718K Hold
18,505
– – 0.22% 89
2024
Q1 		$596K Buy
18,505
+417
+2% +$12.4K 0.17% 111
2023
Q4 		$519K Hold
18,088
– – 0.17% 119
2023
Q3 		$501K Hold
18,088
– – 0.18% 118
2023
Q2 		$484K Hold
18,088
– – 0.17% 118
2023
Q1 		$392K Buy
18,088
+3,963
+28% +$97.6K 0.15% 132
2022
Q4 		$336K Buy
+14,125
New +$300K 0.14% 141
2021
Q3 		– Sell
-6,725
Closed -$213K – 204
2021
Q2 		$213K Hold
6,725
– – 0.07% 191
2021
Q1 		$309K Buy
+6,725
New +$302K 0.11% 156

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fernwood Investment Management's RVMD Position: Q4 2024 in Review

Fernwood Investment Management held its Revolution Medicines (RVMD) position steady in Q4 2024 at 18,505 shares worth $809K. The position accounts for 0.28% of the portfolio, ranked #74.

Fernwood Investment Management first reported a position in RVMD in Q1 2021 and has held it in 11 quarters since. The position peaked at $839K in Q3 2024. 281 funds tracked by Wall St. Rank hold RVMD as of Q4 2024.

  • Fernwood Investment Management held 18,505 shares of Revolution Medicines worth $809K as of Q4 2024.
  • Fernwood Investment Management left its Revolution Medicines share count unchanged in Q4 2024.
  • Revolution Medicines made up 0.28% of Fernwood Investment Management's portfolio in Q4 2024, its #74 holding.
  • Fernwood Investment Management first reported a position in Revolution Medicines in Q1 2021 and has held it in 11 quarters since.
  • Fernwood Investment Management's Revolution Medicines position peaked at $839K in Q3 2024.
  • 281 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.